Boston Scientific Corp
Technische Signale
| Signale Details | |
|---|---|
| WKN / ISIN | - / - |
| Börse | NYSE |
| Schluss | 83,62 |
| Konservatives Signal |  18.10.24 |
| MACD |  20.08.24 |
| Momentum | 16.08.24 |
| Bollinger Bands | 26.07.24 |
| TBI | 20.08.24 |
| Schnitt GD 90 | 08.08.24 |
Analystenbewertung
| Bewertungstrend | aktuell | Vorwoche | Vormonat |
|---|---|---|---|
| Bewertung | 1,55 | 1,55 | 1,52 |
| Anzahl der Analysten | 33 | 33 | 33 |
| Kaufen | 20 | 20 | 20 |
| Übergewichten | 8 | 8 | 9 |
| Halten | 5 | 5 | 4 |
| Untergewichten | 0 | 0 | 0 |
| Verkaufen | 0 | 0 | 0 |
| Aktueller Durchschnitt von insgesamt 33 Analysten: 1,55 | |||
| Planzahlen (in EUR) | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Umsatz | 14,24 Mrd. | 16,28 Mrd. | 18,04 Mrd. |
| EBIT | 2,07 Mio. | 4,38 Mrd. | 4,95 Mrd. |
| EBITDA | 3,17 Mio. | 4,80 Mrd. | 5,45 Mrd. |
| Nettoverschuldung** | 6,87 Mrd. | 6,57 Mrd. | 3,66 Mrd. |
Umsatz |
EBIT |
EBITDA |
Nettoverschuldung** |
| Dividende | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Dividende / Aktie | 0,00 EUR | 0,00 USD | 0,00 USD |
| Dividendenrendite | 0,00% | 0,00% | 0,00% |
Dividende / Aktie (in USD) |
Dividendenrendite (in %) |
||
| Analystenhäuser |
|---|
| Argus Research Company,Atlantic Equities LLP,Baird,Baptista Research,Barclays,Benchmark Company,BMO Capital Markets Equity Research,BMO Capital Markets U.S. (Historical),BofA Global Research,Brean Capital,BTIG,Canaccord Genuity,Caris & Company,CFRA Equity Research,Citigroup Inc,CL King & Associates, Inc.,Cleveland Research Company,Collins Stewart LLC,Craig-Hallum Capital Group LLC,Credit Suisse,Crisp Idea,CRT Capital Group,Daiwa Capital Markets America Inc.,Daiwa Securities Co. Ltd.,Deutsche Bank,DISCERN Investment Analytics,Equisights,Evercore ISI,G. Research, LLC,Goldman Sachs,Guggenheim Securities, LLC,J.P. Morgan,Jefferies LLC,JMP Securities,Kaufman Bros., L.P.,Lazard Capital Markets,Leerink Partners LLC,Maxim Group,Mirae Asset Securities Co., Ltd.,Mizuho Securities USA LLC,Morgan Joseph TriArtisan LLC,Morgan Keegan & Company,Morgan Stanley,Morningstar Inc.,Needham & Company,NOBLE Capital Markets, Inc.,Nomura Securities Co. Ltd.,Northland Capital Markets,Oppenheimer & Co. Inc.,Piper Sandler Companies,Raymond James & Associates,RBC Capital Markets,Redburn Atlantic,Sanford C. Bernstein & Co., LLC,Stephens, Inc.,Sterne Agee & Leach,Stifel, Equities Research,TD Cowen,Truist Securities,UBS Investment Bank,Wedbush Securities Inc.,Weeden & Co., LP,Wells Fargo Securities, LLC,Wolfe Research, LLC.,Zephirin Group, Inc. |
| Hinweis |
|---|
|
Selected Data supplied by Standard & Poors
* Unabhängige Schätzung (Gewinnwachstum (in %)) ** Nettobargeldbestand bei negativen Schätzungen |